Hypertension, Vol 11, 491-494, Copyright © 1988 by American Heart Association
A Fujimura and A Ebihara
The role of plasma angiotensin II (Ang II) in furosemide-stimulated renal
prostaglandin E2 (PGE2) production was evaluated in eight healthy subjects.
Urine was collected for 60 minutes after furosemide administration (20 mg
i.v.) with or without captopril pretreatment, and urinary excretion of
PGE2, sodium, and furosemide was determined. Plasma renin activity (PRA)
and Ang II were also measured before and 60 minutes after furosemide
administration. Urinary PGE2 excretion, PRA, and Ang II increased after
furosemide administration without captopril pretreatment, and there was a
significant correlation between the increment in Ang II and that in urinary
PGE2 excretion. Urinary PGE2 excretion and Ang II did not increase after
furosemide administration with captopril pretreatment. Urine volume and
urinary excretion of sodium and furosemide were not influenced by captopril
pretreatment. These results suggest that Ang II may play an important role
in furosemide-stimulated PGE2 production.
ARTICLES
Role of angiotensin II in renal prostaglandin E2 production after furosemide administration
Department of Clinical Pharmacology, Oita Medical School, Japan.
This article has been cited by other articles:
![]() |
Q. Yan, X. Yang, A. Cantone, G. Giebisch, S. Hebert, and T. Wang Female ROMK null mice manifest more severe Bartter II phenotype on renal function and higher PGE2 production Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R997 - R1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
N E Moghal and M Shenoy Furosemide and acute kidney injury in neonates Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2008; 93(4): F313 - F316. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |